How much funding has Cellivate raised?

Cellivate has raised $1.0M in total funding, most recently a seed round.

Who are Cellivate's investors?

Cellivate's investors include Venture Catalysts, HATCHER+, Waterbridge Ventures, Thinkuvate Ventures.

Where is Cellivate headquartered?

Cellivate is headquartered in Singapore, Singapore.

What industry is Cellivate in?

Cellivate operates in Healthcare, Biotech.

Cellivate

Solving bottlenecks faced by cell-based companies at different stages of the value chain

Singapore, Singapore · Founded 2024 · $1.0M raised

Healthcare

Biotech

Headquarters: Singapore
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: cellivatetech.com
Total Funding: $1.0M
Last Round: $1.0M SeedAug 2024
Rounds: 1

About

Cellivate Technologies is a National University of Singapore spin-off that develops animal-free, proprietary cell culture products. Its flagship BOOSTER product delivers controlled extracellular vesicle-mediated signaling to replace fetal bovine serum, reducing batch-to-batch variability for pharmaceutical, cultivated meat, cosmetics, and biotech applications.

Summary

Cellivate is a Healthcare company based in Singapore, Singapore, founded in 2024. It has raised $1.0M in total across 1 round, most recently a $1.0M Seed round in Aug 2024. Investors include Venture Catalysts, HATCHER+ and Waterbridge Ventures.